Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2004 April;139(2) > Giornale Italiano di Dermatologia e Venereologia 2004 April;139(2):139-43

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

CLINICAL CASES  


Giornale Italiano di Dermatologia e Venereologia 2004 April;139(2):139-43

language: English, Italian

Pemphigus vulgaris and rituximab. Report of a case

Marzocchi V. 1, Virgolini L. 2

1 Unit of Dermatology “S. Maria della Misericordia” Hospital, Udine, Italy
2 Medicine Unit II, Department of Medicine I “S. Maria degli Angeli” Hospital, Pordenone, Italy


PDF  


Pemphigus vulgaris is a serious bullous disease of auto-immune pathogenesis affecting the skin and mucous membranes, caused by the presence of desmosomal anti-cadherin antibodies. The disease is potentially fatal, and is generally treated with immuno-suppressors, usually corticosteroids. This paper describes a case of pemphigus vulgaris which, resistant to all other kinds of therapy, succumbed to rituximab, an anti-CD20 B-cell murine antibody, made suitable for use on humans.

top of page

Publication History

Cite this article as

Corresponding author e-mail